About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT02328456

Effect of SMS Reminder and Free Eye Drops on Follow-up Adherence After Trabeculectomy Surgery in Rural China

The purpose of the study is to use a randomized controlled design to determine the impact of a SMS messaging associated with free eye drops intervention on the following outcomes among patients after ...

Lead sponsor: Congdon Nathan•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Congdon Nathan

Collaborators

Orbis

SMS message reminder is a system which can sent re-visit information to remind the patient about the revisit time and address. The investigators can use the SMS system to find out if it is a useful to reduce the not-attended rate of the revisit appointment among the rural patients.

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•All the patients after trabeculectomy surgery in 4 cooperated rural hospitals

Exclusion Criteria

•Both the patient and his/her caretakers don't have cellphone or the one who has cellphone but don't know how to use the SMS function.

Related studies

BEYOND Study: Improving HIV Treatment and Well-Being Among Young MSM in Vietnam

NCT07559266 · HIV Infections, Mental Health, and more

Strategies for Improving Linkage-to-Care After Eye Disease Screening

NCT06943599 · Age Related Macular Degeneration, Diabetic Retinopathy, and more

The Multi-Omics Analysis of Lens Zonule Relaxation in The PACG Pathogenesis

NCT07539675 · Primary Angle-Closure Glaucoma

Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant

NCT05613010 · Transplant;Failure,Kidney, Transplant; Failure, Liver, and more

Implementing Depression and Adherence Treatment

NCT07032363 · Depression, HIV, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 15, 2016Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment209

Start dateDec 2014

Last updatedApr 15, 2016

Condition

Glaucoma Adherence

Locations shown

Blindness Preventment and Treatment Department

Guangzhou, Guangdong

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 15, 2016Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions